The global live vaccines market was valued at $10,423.4 mn in 2019 and is anticipated to surpass $ 20,020 mn by 2030. In 2019, the North American segment held 39% of the global live vaccines market.

How this report will benefit you
  • Read on to discover how you can exploit the future business opportunities emerging in this sector.
  • In this brand new 213-page report you will receive 138 tables and 65 figures– all unavailable elsewhere.
  • The 213-page report provides clear detailed insight into the live vaccines market. Discover the key drivers and challenges affecting the market.
  • By ordering and reading our brand-new report today you stay better informed and ready to act.
Report Scope

Forecast of the Global Live Vaccines Market by Type of Product:
  • Bacterial
  • Viral
Forecast of the Global Live Vaccines Market by Indication:
  • Oral Polio Vaccine (OPV)
  • Measles
  • Rotavirus
  • Tuberculosis
  • Yellow Fever
  • Others
This report provides individual revenue forecasts to 2030 for these national markets:
  • The US
  • Canada
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Japan
  • China
  • India
  • Brazil
  • Mexico
Our study discusses the selected leading companies that are the major players in the live vaccines market:
  • AstraZeneca
  • Bavarian Nordic A/S
  • DAIICHI SANKYO COMPANY, LIMITED
  • Emergent BioSolutions Inc.
  • GlaxoSmithKline plc
  • Inovio Pharmaceuticals, Inc.
  • & Other Companies
This report discusses factors that drive and restrain this market. As well as opportunities and challenges faced by this market.
This report discusses the SWOT & PEST Analyses of the live vaccines market.